Opsoclonus-Ataxia Syndrome in a Patient With Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Antonio FarinaMacarena VillagránMarie BenaiteauFlorian LamblinAnthony FourierJerome HonnoratBastien JoubertPublished in: Neurology(R) neuroimmunology & neuroinflammation (2024)
The clinical pattern and reversibility bring the present case close to a few patients with paraneoplastic OMAS described before the ICI era. More research is needed to clarify the pathogenesis and outcomes of OMAS in the context of ICI.